pages · PDF
Benzodiazepines work — but at the cost of sedation, dependence, and cognitive blunting. Selank produces comparable anxiolytic effect without those tradeoffs (research-described as comparable to medazepam in generalized anxiety trials). Layered with Semax (BDNF-axis stress resilience) + magnesium glycinate (GABA-A cofactor) for the full protocol.
Unlock: Anxiety Without Benzodiazepines — Selank Quick-Start
Enter your details to get instant access to this free guide.
No spam. We respect your privacy.
“These guides saved me weeks of research. The evidence ratings alone changed how I approach my protocols.”
-- Verified DoseCraft user
Why this matters
If you've been prescribed a benzodiazepine and told that's as good as it gets — the literature describes a different path. Anxiety isn't just a neurotransmitter imbalance. It's frequently downstream of the three biological failures (systemic inflammation, insulin resistance, ATP shortage) that drive HPA-axis hyperactivation. The Selank-anchored neuropeptide stack addresses the anxiolytic layer directly; the systemic addressing of the three failures resolves the substrate. No bro-science. No name-drops.
What you'll learn
- Why Selank produces anxiolytic effects without benzo sedation or dependency
- How HPA-axis hyperactivation is downstream of the three biological failures
- The exact dose, timing, and administration route (intranasal vs SubQ — both work)
- What to expect in week 1, week 4, and at the 12-week mark
- How to layer with existing SSRI or therapy without conflict
- Which medical contributors to rule out at baseline (thyroid, B12, ferritin, cortisol)
- Why magnesium glycinate is the highest-evidence cofactor
- When to add BPC-157 + MOTS-c (the upstream substrate addressing)
The protocol at a glance
Dose
Selank 250–500 mcg intranasal · Semax 200–400 mcg intranasal AM · Magnesium glycinate 400–600 mg oral nightly · L-theanine 200–400 mg oral PRN acute
Frequency
Selank 1–2× daily · Semax once daily AM · Magnesium nightly · L-theanine as-needed
Cycle
Weeks 1–2 loading (Selank 2× daily) · Weeks 3–12 maintenance (Selank 1× daily) · Weeks 13–16 optional taper
Timeline
Acute anxiolytic effect (Selank): 20–30 minutes after first intranasal dose · Subjective baseline shift: 1–2 weeks · BDNF-axis stress resilience (Semax): 2–3 weeks · Full endpoint: 12 weeks
Cautions
Selank's GABAergic activity has not been characterized in published interaction studies with prescription anxiolytics. If you're on an SSRI, benzodiazepine, or SNRI, coordinate with your prescribing clinician before starting. Severe panic disorder, OCD, and PTSD require clinical-primary care — this is adjunct research framing, not replacement for professional care. Active suicidal ideation: seek immediate clinical care.
Is this for you?
- Mild to moderate generalized anxiety with a clear desire to avoid benzo dependency
- Research users already working with a therapist or psychiatrist
- Anyone who has tried SSRIs and found the side-effect profile unacceptable
- Adults 21+ in jurisdictions where research peptides are legal
- Users willing to track labs at baseline to rule out medical anxiety contributors
- Severe panic disorder, OCD, or PTSD — these require clinical-primary care
- Anyone on MAOIs — interaction profile completely uncharacterized
- Active suicidal ideation — seek immediate clinical care
- Pregnancy or breastfeeding
- Under 21 years of age
The mechanism — why it works
Why this protocol — what the benzo literature gets wrong
Standard-of-care anxiety treatment runs through SSRIs (slow onset, sexual side-effect profile) and benzodiazepines (effective short-term, but tolerance and dependency inside 4–8 weeks). Benzodiazepines don't solve anxiety — they suppress it on demand while the underlying neurobiology continues to drift. The Selank-anchored protocol is research-described as different: anxiolytic effect comparable to medazepam in generalized anxiety trials — without the sedation, tolerance, or dependency.
Anxiety as downstream of the three failures
Sustained anxiety often reflects HPA-axis hyperactivation. The HPA axis is downstream of systemic inflammation (cytokines drive cortisol elevation), insulin resistance (insulin signaling affects HPA tone), and ATP shortage (T-regulatory cells and neuronal energy both fail without sufficient ATP). The peptide-anxiolytic protocol addresses the neurochemical layer; addressing the three failures (BPC-157 for inflammation, MOTS-c for ATP/insulin) addresses the substrate that keeps producing the anxiety signal. For chronic anxiety, both layers are typically needed.
Selank — multi-pathway anxiolysis without sedation
Heptapeptide derived from tuftsin. Trial data describes anxiolytic effect comparable to medazepam (a benzodiazepine) in generalized anxiety disorder — without the sedation, tolerance, or dependency. The mechanism is distinct: Selank modulates GABA-A activity, serotonergic tone, and BDNF upregulation simultaneously. The anxiolysis-without-sedation pattern is the result of this multi-pathway action rather than simple GABAergic suppression. Standard dose: 250–500 mcg/day intranasal. Russian trial corpus describes continuous use up to 12 months without tolerance development.
Semax — BDNF-axis stress resilience
ACTH(4-10) fragment. The literature describes anxiolytic, nootropic, and neuroprotective effects via BDNF and NGF upregulation. Selank handles the acute anxiolytic layer (GABA modulation). Semax handles the slower BDNF-axis stress-resilience layer — by week 3, most users describe handling normally-stressful situations with less reactivity, not because the stressor changed but because the CNS response did. Standard dose: 200–400 mcg/day intranasal, AM only. Afternoon dosing produces sleep disruption.
Magnesium glycinate — the cofactor floor
Roughly 50% of US adults are suboptimal in magnesium status. Chronic stress depletes magnesium via cortisol-driven urinary excretion. Trial data describes anxiolytic and sleep-onset benefits at 400 mg+ daily. Glycinate form is preferred over oxide (laxative-dose) or citrate (less sleep-specific). Standard dose: 400–600 mg/day, larger fraction in the evening.
L-theanine — the acute PRN lever
Amino acid found in tea. Trial data describes acute anxiolytic effect within 30–60 minutes via glutamatergic modulation and alpha-wave EEG induction. Use case: PRN lever for acute stressor spikes when Selank + Semax handle daily baseline but life delivers an obvious trigger. Non-prescription, no controlled-substance status, well-tolerated at any reasonable dose. Standard dose: 200–400 mg as needed, up to 3–4× daily.
Intranasal administration technique
Tilt your head slightly forward. Instill into each nostril in alternating passes. Sniff gently — don't forcefully inhale. The olfactory pathway gives direct CNS access; that's why intranasal onset is faster than SubQ for these peptides. SubQ works at the same dose with slightly delayed onset — many users prefer SubQ for convenience and consistency.
What you'll feel — week by week
Week 1
Selank onset within 20–30 minutes of the first intranasal dose. Most users describe a reduction in baseline tension rather than sedation — the difference between 'calm' and 'blunted.' Magnesium glycinate typically improves sleep onset within the first week.
Week 2
Stress-resilience improvements start to show. The Semax BDNF-axis effect is slower than Selank's acute anxiolytic effect — most users describe noticing they're handling normally-stressful situations with less reactivity.
Weeks 4–6
The fuller picture. AM cortisol pattern typically normalizes in bloodwork by week 6. The weekly score gap between 'baseline anxiety' and 'current anxiety' becomes consistently measurable.
Week 12
Full protocol endpoint. The literature describes sustained benefit in users who complete the full 12-week cycle. Reassess: do you need a second cycle, a maintenance protocol, or has the baseline reset been achieved? For users with persistent anxiety here, consider adding the upstream substrate-addressing layer (BPC-157 + MOTS-c).
What could go wrong
Common (no action)
- Mild nasal irritation with intranasal administration — normal in first few uses, resolves
- Slight stimulant feeling with Semax in the morning — expected; avoid afternoon dosing
- Very mild headache in first 2–3 days — typically resolves without intervention
- Vivid dreams in week 1 — reported by minority of users, resolves by week 2
Watch + adjust
- Increased anxiety in first 3–5 days — paradoxical anxiety with new anxiolytic compounds is rare but described; hold dose steady, usually resolves
- Persistent headache beyond first week — reduce Semax dose first (most likely culprit)
- Sleep disruption if Semax is taken in the afternoon or evening — move dose to strict AM
Stop + seek care
- Worsening anxiety with suicidal ideation — stop immediately, seek clinical care
- Severe allergic reaction (hives, difficulty breathing) — seek emergency care
- Any symptom your doctor would classify as a medical emergency
Bloodwork — what to track
Highest-yield baseline tests: TSH + free T4 (hyperthyroid is the most common missed medical anxiety driver), AM cortisol (HPA-axis baseline; tracks normalization), vitamin D (25-OH; deficiency independently associated with anxiety), vitamin B12 (target > 400 pg/mL), ferritin (iron deficiency produces anxiety before frank anemia), CMP (electrolyte/kidney/liver screen). Full bloodwork target table + tracker worksheet in the paid pack.
Frequently asked
Selank vs benzodiazepines — what's actually different?
Benzodiazepines bind GABA-A with high affinity and produce sedation, tolerance, and dependency because they're flooding a single receptor. Selank modulates GABA-A more subtly, adds serotonergic and BDNF-axis effects, and the trial data shows no tolerance at 6–12 months. The subjective experience is described as calm without blunting — you're still fully present, just not reactive.
Can I take Selank every day or do I need to cycle?
Russian clinical practice describes continuous use up to 12 months without tolerance or dependency. For research-frequency use, 12-on / 4-off cycling is the conservative pattern. The literature doesn't mandate cycling — but building in breaks is prudent given the limited Western long-duration human data.
I'm on an SSRI. Is it safe to add Selank?
Russian clinical research describes Selank as adjunct-compatible with SSRIs. Western pharmacokinetic interaction studies don't exist for this combination. Discuss with your prescribing clinician. The theoretical risk is low given distinct mechanisms, but clinical validation in your specific combination is limited.
What if I can't get intranasal Selank — can I use SubQ?
SubQ works at the same dose range (250–500 mcg) with slightly delayed onset compared to intranasal. The anxiolytic effect is described as equivalent in the research. Many users prefer SubQ for convenience and consistency of dosing.
Cited research
Verified Vendors
Where to get these compounds
Selank and Semax are research peptides — Russian-origin neuropeptide research canon. Source from a verified vendor below. Magnesium glycinate and L-theanine are supplements (any reputable source).
Peptide Partners
Practitioner-tier research peptides
HPLC + Mass-Spec verified · Free replacement on failed third-party tests
MyOasis Labs
Widest catalog — injectables, oral caps, blends
Third-party lab tested · Every batch
Hydro Research Peptides
Research-grade peptides — 20% off your order
Research peptides · newest addition to the verified roster
Affiliate disclosure: DoseCraft earns a small commission on orders made through these vendor links — at no extra cost to you. We only partner with vendors that pass our internal vendor-rubric audit.
Ready for the full experience?
DoseCraft gives you AI-powered protocol building, 90+ compound library, dose tracking, and evidence-rated stacks from leading practitioners.
Get Started — Try DoseCraft NowNot medical advice — educational only. These guides are for informational and research purposes only. Always consult a licensed healthcare professional before starting any peptide protocol.